# A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF

> **NCT00765050** · PHASE1,PHASE2 · TERMINATED · sponsor: **PETHEMA Foundation** · enrollment: 13 (actual)

## Conditions studied

- Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF

## Interventions

- **BIOLOGICAL:** CD133+ cells transplant

## Key facts

- **NCT ID:** NCT00765050
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765050, "A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00765050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*